Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg-interferon-alpha vs Nucleoside Analogue in HBeAg-positive CHB
NCT01769833Phase 3Unknown
- Sponsor
- Pusan National University Hospital
- Start
- May 2013
- Primary completion
- May 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa in Chronic Hepatitis B (CHB), sponsored by Pusan National University Hospital. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01769833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769833.